VRF Eye Specialty Group, PLC
VRF Eye Specialty Group, PLC was paid $2.53M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 66984, Extracapsular cataract removal with insertion of intraocular lens prosthesis — 19% of everything it billed.
33Billing provider infoVRF EYE SPECIALTY GROUP, PLC
MEMPHIS, TN 38120
MEMPHIS, TN 38120
33aNPI1699729806assigned 05/20/2006
33bProvider typeOptometrist
28Total paid$2.53M
24GClaims108,761
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Optometrist providers in Tennessee
Rank by total paid#6 of 698
Median peer was paid$19K
This provider vs. median133×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,906 | $296K | |
| 2019 | 16,020 | $343K | |
| 2020 | 13,539 | $397K | |
| 2021 | 18,380 | $468K | |
| 2022 | 19,862 | $458K | |
| 2023 | 19,454 | $380K | |
| 2024incomplete | 9,600 | $191K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 19% | 6,186 | 4,447 | $491K |
| 67028 | Intravitreal injection of a pharmacologic agent | 13% | 6,799 | 4,403 | $319K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 11% | 7,568 | 6,153 | $284K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.4% | 15,615 | 11,960 | $213K |
| 92134 | 5.7% | 12,740 | 9,231 | $144K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.0% | 6,824 | 4,919 | $127K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 4.9% | 5,696 | 4,761 | $125K |
| J9035 | Injection, bevacizumab, 10 mg | 4.8% | 4,115 | 2,816 | $122K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 3.9% | 2,121 | 1,655 | $100K |
| 92136 | 2.9% | 9,259 | 5,573 | $74K | |
| 92083 | 2.7% | 3,690 | 2,982 | $69K | |
| 92015 | Determination of refractive state | 2.5% | 4,496 | 3,589 | $64K |
28 more codes
| S0620 | Routine ophthalmological examination including refraction; new patient | 2.2% | 1,576 | $57K |
| 92133 | 2.1% | 4,603 | $53K | |
| 92235 | 1.3% | 1,436 | $32K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.2% | 1,593 | $32K |
| V2020 | Frames, purchases | 1.2% | 1,983 | $30K |
| 93890 | 1.1% | 591 | $27K | |
| 93886 | 1.0% | 642 | $26K | |
| 93892 | 1.0% | 615 | $26K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 883 | $25K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,872 | $19K |
| 92250 | <1% | 1,208 | $18K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 436 | $16K |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 1,512 | $12K |
| 66183 | <1% | 57 | $7K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 217 | $6K |
| 92020 | <1% | 1,119 | $5K | |
| 67228 | <1% | 57 | $3K | |
| J0178 | Injection, aflibercept, 1 mg | <1% | 41 | $2K |
| S0621 | Routine ophthalmological examination including refraction; established patient | <1% | 59 | $1K |
| 92225 | <1% | 144 | $1K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 57 | $684.18 |
| 92002 | <1% | 19 | $405.99 | |
| 92341 | <1% | 13 | $347.64 | |
| 76514 | <1% | 103 | $305.01 | |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 45 | $30.00 |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 2,598 | $24.00 |
| J7999 | Compounded drug, not otherwise classified | <1% | 26 | $14.63 |
| 99024 | 0% | 147 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOLLAMUDI, SUBBA (CHIEF MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Ridge Lake Asc, LLC | Memphis, TN | $390K |
| Eye Care Surgery Center of Southaven,llc | Southaven, MS | $153K |
| Eye Care Surgery Center of Memphis, LLC | Memphis, TN | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.